GEODE CAPITAL MANAGEMENT, LLC - MEDICENNA THERAPEUTICS CORP ownership

MEDICENNA THERAPEUTICS CORP's ticker is MDNA and the CUSIP is 58490H107. A total of 28 filers reported holding MEDICENNA THERAPEUTICS CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of MEDICENNA THERAPEUTICS CORP
ValueSharesWeighting
Q3 2023$9,761
-40.3%
34,1440.0%0.00%
Q2 2023$16,354
-26.3%
34,1440.0%0.00%
Q1 2023$22,193
+138606.2%
34,1440.0%0.00%
Q4 2022$16
-99.9%
34,1440.0%0.00%
Q3 2022$28,000
-28.2%
34,1440.0%0.00%
Q2 2022$39,000
-9.3%
34,1440.0%0.00%
Q1 2022$43,000
-4.4%
34,144
+23.6%
0.00%
Q4 2021$45,000
-40.8%
27,6330.0%0.00%
Q3 2021$76,000
+13.4%
27,633
+23.2%
0.00%
Q2 2021$67,000
-16.2%
22,436
+13.5%
0.00%
Q1 2021$80,00019,7620.00%
Other shareholders
MEDICENNA THERAPEUTICS CORP shareholders Q4 2022
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 350,000$1,054,0000.54%
AIGH Capital Management LLC 915,000$2,768,0000.50%
AWM Investment Company, Inc. 1,000,000$3,017,0000.30%
Board of Trustees of The Leland Stanford Junior University 962,932$2,898,0000.27%
Worth Venture Partners, LLC 215,030$647,0000.24%
SILVERARC CAPITAL MANAGEMENT, LLC 110,515$333,0000.15%
INTACT INVESTMENT MANAGEMENT INC. 385,600$1,427,0000.04%
Verition Fund Management LLC 539,051$1,623,0000.02%
Patriot Financial Group Insurance Agency, LLC 22,900$69,0000.01%
Maven Securities LTD 79,118$234,0000.01%
View complete list of MEDICENNA THERAPEUTICS CORP shareholders